The Cooper Companies, Inc. (NASDAQ:COO) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of The Cooper Companies, Inc. (NASDAQ:COO) have received an average rating of “Moderate Buy” from the sixteen ratings firms that are covering the company, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, six have given a hold recommendation, eight have issued a buy recommendation and one has given a strong buy recommendation to the company. The average twelve-month price objective among analysts that have issued ratings on the stock in the last year is $90.7692.

Several brokerages have recently issued reports on COO. Morgan Stanley increased their price objective on Cooper Companies from $76.00 to $83.00 and gave the company an “equal weight” rating in a research note on Monday, December 8th. Citigroup reiterated a “neutral” rating and issued a $88.00 price objective (up previously from $72.00) on shares of Cooper Companies in a report on Monday, December 8th. KeyCorp reaffirmed a “sector weight” rating on shares of Cooper Companies in a report on Friday, December 5th. Weiss Ratings raised shares of Cooper Companies from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, January 12th. Finally, Piper Sandler restated an “overweight” rating and issued a $94.00 target price (up previously from $83.00) on shares of Cooper Companies in a report on Friday, December 5th.

Cooper Companies Stock Down 1.6%

Shares of NASDAQ COO opened at $81.70 on Friday. The company has a quick ratio of 1.13, a current ratio of 1.89 and a debt-to-equity ratio of 0.30. The firm has a market cap of $16.01 billion, a price-to-earnings ratio of 43.46, a PEG ratio of 2.37 and a beta of 1.03. Cooper Companies has a 52-week low of $61.78 and a 52-week high of $94.17. The business’s 50 day moving average is $81.80 and its two-hundred day moving average is $74.75.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, December 4th. The medical device company reported $1.15 EPS for the quarter, beating analysts’ consensus estimates of $1.11 by $0.04. The company had revenue of $1.07 billion during the quarter, compared to analysts’ expectations of $1.06 billion. Cooper Companies had a return on equity of 10.02% and a net margin of 9.16%.Cooper Companies’s revenue for the quarter was up 4.6% on a year-over-year basis. During the same period last year, the business posted $1.04 EPS. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. Research analysts predict that Cooper Companies will post 3.98 EPS for the current year.

Insider Buying and Selling at Cooper Companies

In other news, CEO Albert G. White III bought 10,000 shares of Cooper Companies stock in a transaction dated Tuesday, December 16th. The stock was acquired at an average cost of $80.80 per share, with a total value of $808,000.00. Following the acquisition, the chief executive officer owned 236,151 shares of the company’s stock, valued at approximately $19,081,000.80. This trade represents a 4.42% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Lawrence Erik Kurzius bought 2,000 shares of the firm’s stock in a transaction that occurred on Wednesday, December 17th. The stock was purchased at an average cost of $82.50 per share, with a total value of $165,000.00. Following the completion of the transaction, the director owned 7,777 shares in the company, valued at approximately $641,602.50. This trade represents a 34.62% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last three months, insiders have acquired 16,014 shares of company stock valued at $1,304,416. 1.98% of the stock is owned by insiders.

Hedge Funds Weigh In On Cooper Companies

A number of hedge funds have recently modified their holdings of COO. Vanguard Group Inc. boosted its stake in Cooper Companies by 1.8% during the 2nd quarter. Vanguard Group Inc. now owns 24,254,677 shares of the medical device company’s stock worth $1,725,963,000 after purchasing an additional 421,423 shares during the period. Capital World Investors raised its holdings in shares of Cooper Companies by 25.7% in the third quarter. Capital World Investors now owns 10,551,592 shares of the medical device company’s stock valued at $723,417,000 after buying an additional 2,159,233 shares during the last quarter. State Street Corp boosted its stake in shares of Cooper Companies by 1.2% during the second quarter. State Street Corp now owns 8,659,741 shares of the medical device company’s stock worth $616,227,000 after buying an additional 104,910 shares during the period. Wellington Management Group LLP boosted its stake in shares of Cooper Companies by 332.9% during the third quarter. Wellington Management Group LLP now owns 6,184,992 shares of the medical device company’s stock worth $424,043,000 after buying an additional 4,756,178 shares during the period. Finally, Geode Capital Management LLC grew its holdings in shares of Cooper Companies by 2.5% during the second quarter. Geode Capital Management LLC now owns 5,205,615 shares of the medical device company’s stock worth $368,893,000 after buying an additional 127,907 shares during the last quarter. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.